A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Clinical trial NCT03815695 · COMPLETED

Trial details

NCT number: NCT03815695
Sponsor: Forma Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Sickle Cell Disease

Start date: 2018-12-11
Primary completion: 2021-12-17
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.